This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
For context, the AAV9 that is often used in gene therapies has a packaging limit of 4,700 DNA bases.) Future Nobel Laureate, Paul Berg, narrated the video, which quickly became a cult classic moment in molecularbiology history. A writing workshop was followed by pizza and rosé Thanks to everyone who showed up.
For context, the AAV9 that is often used in gene therapies has a packaging limit of 4,700 DNA bases.) Future Nobel Laureate, Paul Berg, narrated the video, which quickly became a cult classic moment in molecularbiology history. A writing workshop was followed by pizza and rosé Thanks to everyone who showed up.
a recombinant protein or gene therapy packaged via AAV virus) which has been produced by the cells, in addition to other debris such as the remaining media and the remnants of the cells. For more background, read AgencyIQ’s analysis of a recent workshop where FDA sought input on the building blocks for platform technology designation.]
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content